CERo Therapeutics Holdings, Inc
Ticker(s):
CERO and CEROW
Country:
Sector & Industry:
Business Overview
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.
Contact & Other Information
Number of Employees:
8
Website:
201 Haskins Way
Suite 230
South San Francisco
,
CA
,
94080
United States
215 731 9450
No content was found.